UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.680

Sortiert nach

Immunology and Immunotherapy of Head and Neck Cancer

Journal of clinical oncology, 2015-10, Vol.33 (29), p.3293-3304

Ferris, Robert L

2015

Link zum Volltext

Verfügbarkeit prüfen

The changing therapeutic landscape of head and neck cancer

Nature reviews. Clinical oncology, 2019-11, Vol.16 (11), p.669-683

2019

Link zum Volltext

Verfügbarkeit prüfen

Immunotherapy for head and neck cancer: Recent advances and future directions

Oral oncology, 2019-12, Vol.99, p.104460-104460, Article 104460

2019

Link zum Volltext

Verfügbarkeit prüfen

Transoral Endoscopic Head and Neck Surgery and Its Role Within the Multidisciplinary Treatment Paradigm of Oropharynx Cancer: Robotics, Lasers, and Clinical Trials

Journal of clinical oncology, 2015-10, Vol.33 (29), p.3285-3292

2015

Link zum Volltext

Verfügbarkeit prüfen

TIM-3 as a Target for Cancer Immunotherapy and Mechanisms of Action

International journal of molecular sciences, 2017-03, Vol.18 (3), p.645-645

2017

Link zum Volltext

Verfügbarkeit prüfen

PD‐1 targeting in cancer immunotherapy

Cancer, 2013-12, Vol.119 (23), p.E1-E3

Ferris, Robert

2013

Link zum Volltext

Verfügbarkeit prüfen

Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer

Immunity (Cambridge, Mass.), 2020-01, Vol.52 (1), p.183-199.e9

2020

Link zum Volltext

Verfügbarkeit prüfen

Immunotherapy for Head and Neck Squamous Cell Carcinoma

Current oncology reports, 2018-02, Vol.20 (2), p.22-7, Article 22

2018

Link zum Volltext

Verfügbarkeit prüfen

Oropharyngeal Carcinoma with a Special Focus on HPV-Related Squamous Cell Carcinoma

Annual review of pathology, 2023-01, Vol.18, p.515

2023

Link zum Volltext

Verfügbarkeit prüfen

Analytical performance of the ThyroSeq v3 genomic classifier for cancer diagnosis in thyroid nodules

Cancer, 2018-04, Vol.124 (8), p.1682-1690

2018

Link zum Volltext

Verfügbarkeit prüfen

Head and neck cancer

The Lancet (British edition), 2008-05, Vol.371 (9625), p.1695-1709

2008

Link zum Volltext

Verfügbarkeit prüfen

Biological mechanisms of immune escape and implications for immunotherapy in head and neck squamous cell carcinoma

European journal of cancer (1990), 2017-05, Vol.76, p.152-166

2017

Link zum Volltext

Verfügbarkeit prüfen

Promising progress from Healthy People 2020 and cancer incidence update

Cancer, 2020-05, Vol.126 (10), p.2114-2115

Ferris, Robert L.

2020

Link zum Volltext

Verfügbarkeit prüfen

Too much of a good thing? Tim-3 and TCR signaling in T cell exhaustion

The Journal of immunology (1950), 2014-08, Vol.193 (4), p.1525-1530

2014

Link zum Volltext

Verfügbarkeit prüfen

Tumor Antigen–Targeted, Monoclonal Antibody–Based Immunotherapy: Clinical Response, Cellular Immunity, and Immunoescape

Journal of clinical oncology, 2010-10, Vol.28 (28), p.4390-4399

2010

Link zum Volltext

Verfügbarkeit prüfen

Adaptive resistance to anti-PD1 therapy by Tim-3 upregulation is mediated by the PI3K-Akt pathway in head and neck cancer

Oncoimmunology, 2017-01, Vol.6 (1), p.e1261779-e1261779

2017

Link zum Volltext

Verfügbarkeit prüfen

Phase II Randomized Trial of Transoral Surgery and Low-Dose Intensity Modulated Radiation Therapy in Resectable p16+ Locally Advanced Oropharynx Cancer: An ECOG-ACRIN Cancer Research Group Trial (E3311)

Journal of clinical oncology, 2022-01, Vol.40 (2), p.138-149

2022

Link zum Volltext

Verfügbarkeit prüfen

PD-1 immunotherapy for recurrent or metastatic HNSCC

The Lancet (British edition), 2019-11, Vol.394 (10212), p.1882-1884

2019

Link zum Volltext

Verfügbarkeit prüfen

Reply to A.S. Garden

Journal of clinical oncology, 2022-04, Vol.40 (10), p.1133-1134

2022

Link zum Volltext

Verfügbarkeit prüfen

Improving head and neck cancer therapies by immunomodulation of the tumour microenvironment

Nature reviews. Cancer, 2023-03, Vol.23 (3), p.173

2023

Link zum Volltext

Verfügbarkeit prüfen

Rationale for combination of therapeutic antibodies targeting tumor cells and immune checkpoint receptors: Harnessing innate and adaptive immunity through IgG1 isotype immune effector stimulation

Cancer treatment reviews, 2018-02, Vol.63, p.48-60

2018

Link zum Volltext

Verfügbarkeit prüfen

B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma

Nature communications, 2021-06, Vol.12 (1), p.3349-3349, Article 3349

2021

Link zum Volltext

Verfügbarkeit prüfen

Utility of CD8 score by automated quantitative image analysis in head and neck squamous cell carcinoma

Oral oncology, 2018-11, Vol.86, p.278-287

2018

Link zum Volltext

Verfügbarkeit prüfen

Sentinel Lymph Node Biopsy Versus Elective Neck Dissection for Stage I to II Oral Cavity Cancer

The Laryngoscope, 2019-01, Vol.129 (1), p.162-169

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.680

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.437)
Mit Volltextzugriff
(1.436)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(80)
Head & Neck
(71)
Otolaryngology-Head And Neck Surgery
(51)
Clinical Cancer Research
(46)
Oral Oncology
(42)
Cancer Research
(40)
Ophthalmology
(39)
Journal For Immunotherapy Of Cancer
(37)
Cancer
(30)
The Laryngoscope
(25)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(12)

Menü

Weitere Dienste

Einstellungen

Immunology and Immunotherapy of Head and Neck Cancer

The changing therapeutic landscape of head and neck cancer

Immunotherapy for head and neck cancer: Recent advances and future directions

Transoral Endoscopic Head and Neck Surgery and Its Role Within the Multidisciplinary Treatment Paradigm of Oropharynx Cancer: Robotics, Lasers, and Clinical Trials

TIM-3 as a Target for Cancer Immunotherapy and Mechanisms of Action

PD‐1 targeting in cancer immunotherapy

Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer

Immunotherapy for Head and Neck Squamous Cell Carcinoma

Oropharyngeal Carcinoma with a Special Focus on HPV-Related Squamous Cell Carcinoma

Analytical performance of the ThyroSeq v3 genomic classifier for cancer diagnosis in thyroid nodules

Head and neck cancer

Biological mechanisms of immune escape and implications for immunotherapy in head and neck squamous cell carcinoma

Promising progress from Healthy People 2020 and cancer incidence update

Too much of a good thing? Tim-3 and TCR signaling in T cell exhaustion

Tumor Antigen–Targeted, Monoclonal Antibody–Based Immunotherapy: Clinical Response, Cellular Immunity, and Immunoescape

Adaptive resistance to anti-PD1 therapy by Tim-3 upregulation is mediated by the PI3K-Akt pathway in head and neck cancer

Phase II Randomized Trial of Transoral Surgery and Low-Dose Intensity Modulated Radiation Therapy in Resectable p16+ Locally Advanced Oropharynx Cancer: An ECOG-ACRIN Cancer Research Group Trial (E3311)

PD-1 immunotherapy for recurrent or metastatic HNSCC

Reply to A.S. Garden

Improving head and neck cancer therapies by immunomodulation of the tumour microenvironment

Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial

Rationale for combination of therapeutic antibodies targeting tumor cells and immune checkpoint receptors: Harnessing innate and adaptive immunity through IgG1 isotype immune effector stimulation

B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma

Utility of CD8 score by automated quantitative image analysis in head and neck squamous cell carcinoma

Sentinel Lymph Node Biopsy Versus Elective Neck Dissection for Stage I to II Oral Cavity Cancer

Suchergebnisse filtern